文献速递生殖医学

NEAT1通过miR-130a-3p/BMP6轴抑制卵巢颗粒细胞凋亡并促进细胞生长和迁移

NEAT1 inhibits granulosa cell apoptosis and promotes cell growth and migration through the miR-130a-3p/BMP6 axis.
PubMed 文献 · Reprod Biomed Online · 2025-02-19

研究比较卵巢储备功能减退(DOR)与正常卵巢储备(NOR)女性卵泡液中卵巢颗粒细胞NEAT1、miR-130a-3p和BMP6的表达,并在KGN细胞中通过基因沉默和过表达探究NEAT1功能。DOR来源颗粒细胞NEAT1和BMP6表达显著降低、miR-130a-3p升高;NEAT1过表达促进KGN细胞增殖和迁移、抑制凋亡,该效应可被miR-130a-3p模拟物部分减弱。结论认为NEAT1通过miR-130a-3p/BMP6轴抑制颗粒细胞凋亡并促进增殖和迁移,可能改善DOR患者卵母细胞质量。

要点

  • DOR来源卵巢颗粒细胞NEAT1和BMP6表达较NOR显著降低,miR-130a-3p表达升高(P < 0.001)。
  • NEAT1过表达促进KGN细胞增殖和迁移、抑制凋亡(P < 0.001),可被miR-130a-3p模拟物部分减弱。
  • 抑制miR-130a-3p可减少KGN细胞凋亡并增强增殖和迁移(P < 0.001),BMP6沉默可部分逆转。

核心结论

  • NEAT1通过miR-130a-3p/BMP6轴抑制卵巢颗粒细胞凋亡并促进增殖和迁移,可能改善DOR患者卵母细胞质量。
  • 作者认为NEAT1可能是DOR的潜在预后生物标志物和治疗靶点。

研究设计与样本

  • 收集20例取卵女性卵泡液,其中DOR 10例、NOR 10例,分离卵巢颗粒细胞检测NEAT1、miR-130a-3p和BMP6表达。
  • 使用颗粒细胞样肿瘤细胞系KGN,通过基因沉默和过表达研究NEAT1功能。
  • 临床试验注册号ChiCTR2400079975。

主要发现

  • DOR来源卵巢颗粒细胞NEAT1和BMP6表达较NOR来源显著降低(P < 0.001),miR-130a-3p表达升高(P < 0.001)。
  • NEAT1表达与胚胎数(r = 0.505,P = 0.023)、优质胚胎数(r = 0.757,P < 0.001)、双原核受精率(r = 0.477,P = 0.033)和获卵数(r = 0.511,P = 0.021)呈正相关。
  • 双荧光素酶报告实验显示miR-130a-3p直接结合NEAT1和BMP6 3'UTR(P < 0.001)。
  • NEAT1过表达显著促进KGN细胞增殖和迁移并抑制凋亡(P < 0.001),该效应可被miR-130a-3p模拟物转染部分减弱。
  • 抑制miR-130a-3p显著减少KGN细胞凋亡并增强增殖和迁移(P < 0.001),BMP6沉默可部分逆转这些效应。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What are the molecular mechanisms of action of nuclear paraspeckle assembly transcript 1 (NEAT1), miR-130a-3p and bone morphogenetic protein 6 (BMP6) in regulating ovarian granulosa cell (OGC) apoptosis and dysfunction in women with diminished ovarian reserve (DOR)? DESIGN: Follicular fluid was collected from 20 women undergoing oocyte retrieval: 10 with DOR and 10 with normal ovarian reserve (NOR). OGC were isolated and assayed for expression of NEAT1, miR-130a-3p and BMP6. Granulosa-like tumour cell line (KGN) cells were used to investigate NEAT1 function by gene silencing and overexpression. RESULTS: NEAT1 and BMP6 expression were significantly lower in DOR-derived OGC compared with NOR-derived OGC (P < 0.001), while miR-130a-3p expression was elevated (P < 0.001). NEAT1 expression was positively correlated with embryo number (r = 0.505, P = 0.023), number of high-quality embryos (r = 0.757, P < 0.001), two-pronuclei fertilization rate (r = 0.477, P = 0.033) and oocyte yield (r = 0.511, P = 0.021). Dual-Luciferase Reporter assays demonstrated that miR-130a-3p binds directly to NEAT1 and BMP6 3'UTR (P < 0.001). Functionally, NEAT1 overexpression significantly promoted the proliferation and migration of KGN cells, while suppressing apoptosis (P < 0.001); these effects were partially attenuated by miR-130a-3p mimic transfection. Conversely, inhibition of miR-130a-3p significantly reduced apoptosis, and enhanced proliferation and migration of KGN cells (P < 0.001); these effects were partially reversed upon BMP6 silencing. CONCLUSIONS: NEAT1 inhibits apoptosis and promotes proliferation and migration of OGC through the miR-130a-3p/BMP6 axis, which may improve oocyte quality in patients with DOR. As such, NEAT1 may be a potential prognostic biomarker and therapeutic target for DOR. CLINICAL TRIAL REGISTRATION NUMBER: ChiCTR2400079975.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Chen W, Dong L, Liang Q, et al. NEAT1 inhibits granulosa cell apoptosis and promotes cell growth and migration through the miR-130a-3p/BMP6 axis. Reprod Biomed Online. 2025. PMID: 41175770. doi:10.1016/j.rbmo.2025.104870

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。